Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 16/20 | 0.52 |
| ▸ | NQO2 | P16083 | 15/20 | 0.52 |
| ▸ | MTNR1B | P49286 | 15/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3752863 | 0.82 | MTNR1A (0.64) | MTNR1ANQO2MTNR1B | |
| SCHEMBL3223390 | 0.80 | ALDH1A1 (0.43) | — | |
| SCHEMBL3210225 | 0.80 | ALDH1A1 (0.43) | — | |
| SCHEMBL3223009 | 0.78 | MTNR1A (0.47) | MTNR1ANQO2MTNR1B | |
| SCHEMBL4427914 | 0.78 | MTNR1A (0.62) | MTNR1ANQO2MTNR1B | |
| SCHEMBL8501324 | 0.78 | MTNR1A (0.62) | MTNR1ANQO2MTNR1B | |
| SCHEMBL2466357 | 0.78 | MTNR1A (0.62) | MTNR1ANQO2MTNR1B | |
| SCHEMBL4017021 | 0.75 | MTNR1A (0.54) | MTNR1ANQO2MTNR1B | |
| SCHEMBL5457802 | 0.75 | PDE4A (0.55) | MTNR1ANQO2MTNR1B | |
| SCHEMBL3208888 | 0.74 | MEN1 (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100048699-A1 | CHEMICAL COMPOUNDS | SYNGENTA CROP PROTECTION, INC. (US) | 2010-02-25 | — | — | US | claimed |
| US-20100048699-A1 | CHEMICAL COMPOUNDS | SYNGENTA CROP PROTECTION, INC. (US) | 2010-02-25 | — | — | US | disclosed |
| EP-2043444-A1 | CHEMICAL COMPOUNDS | Syngenta Limited (GB) | 2009-04-08 | — | — | EP | disclosed |
| WO-2008009881-A1 | CHEMICAL COMPOUNDS | SYNGENTA LIMITED. (GB) | 2008-01-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048699-A1 | CHEMICAL COMPOUNDS | ACHE, TYR, SGMS1 | MTNR1A 1437/4885NQO2 1931/4885MTNR1B 1283/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.